clinical implications of progress in tnbc therapies
Published 2 years ago • 238 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:13
opportunities for novel targets or therapies in tnbc
-
2:05
treatment advances in tnbc
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
2:46
de-escalation of therapy in early-stage tnbc
-
0:41
recent advances in targeted therapies for tnbc
-
1:28
recent developments in treating tnbc with targeted therapies
-
1:26
the association of the her2dx signatures with survival in tnbc
-
1:45
impact of the embark trial on the management of non-metastatic prostate cancer
-
1:15
challenges in tnbc
-
0:51
challenges in the treatment of mtnbc
-
2:30
impassion130: immunotherapy for tnbc
-
1:58
promising novel approaches to the treatment of tnbc
-
1:35
latest updates in mtnbc
-
2:01
ascent: sacituzumab govitecan outperforms chemo in black patients with tnbc
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
1:39
encouraging developments in triple negative breast cancer immunotherapy
-
1:58
targeted therapy in tnbc
-
0:42
can anthracyclines be omitted in tnbc?
-
1:13
predictive markers of response to durvalumab w/nab-paclitaxel doxorubicin/cyclophosphamide in tnbc